Volume 11, Number 6—June 2005
Dispatch
Community-associated Methicillin-resistant Staphylococcus aureus in Pediatric Patients
Theresa J. Ochoa*, John Mohr*, Audrey Wanger*†, James R. Murphy*, and Gloria P. Heresi*
Table 1
Demographic and clinical characteristics of hospitalized pediatric patients with CA-MRSA and CA-MSSA infections*
| Demographic data | No. MRSA (n = 159), (%) | No. MSSA (n = 80), (%) | p value |
|---|---|---|---|
| Age, median (range) | 1.6 y (1.5 mo–17.9 y) | 2.6 y (2 mo–17.7 y) | <0.05 |
| Female sex | 86 (54.0) | 38 (47.5) | NS |
| Ethnicity | |||
| African American | 75 (47.1) | 27 (33.7) | <0.05 |
| Hispanic | 52 (32.7) | 32 (40.0) | NS |
| White | 21 (13.2) | 14 (17.5) | NS |
| Other | 11 (6.9) | 7 (8.7) | NS |
| Clinical data | NS | ||
| Duration bacteremia (d)†, mean ± SD | 2.4 ± 1.8 | 1.1 ± 0.3 | 0.06 |
| Surgical intervention | 140 (88.1) | 57 (70.4) | <0.01 |
| Hospital days, median (range) | 3 (1–53) | 4 (1–38) | NS |
| Intensive care‡ | 13 (8.2) | 10 (12.5) | NS |
*CA, community-associated; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus; NS, not significant; SD, standard deviation.
†Positive blood cultures: 7 MRSA and 9 MSSA.
‡No. patients who required treatment in the pediatric intensive care unit.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.